These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2511239)

  • 1. Growth hormone response to thyrotropin releasing hormone and placebo in a group of insulin dependent diabetic patients.
    Valentini U; Cimino A; Rotondi A; Rocca L; Pelizzari R; Giustina A; Marchetti C; Romanelli G
    J Endocrinol Invest; 1989 Oct; 12(9):643-6. PubMed ID: 2511239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Colasanti S; Barini A
    Metabolism; 1992 Sep; 41(9):949-53. PubMed ID: 1355581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism.
    Chiodera P; Coiro V; Speroni G; Capretti L; Muzzetto P; Volpi R; Butturini U
    J Clin Endocrinol Metab; 1984 Oct; 59(4):794-7. PubMed ID: 6434581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics with or without severe microvascular lesions.
    Blickle JF; Schlienger JL; de Laharpe F; Stephan F
    Diabete Metab; 1982 Sep; 8(3):197-201. PubMed ID: 6814964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous TRH on growth hormone and cortisol serum levels in children and adolescents with insulin dependent diabetes mellitus.
    Vanelli M; Bernasconi S; Bolondi O; Mamì C; Pandullo E; Scaffidi M; Siracusano MF; De Luca F
    J Endocrinol Invest; 1986 Aug; 9(4):293-7. PubMed ID: 3097114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous growth hormone (GH) pulsatility is the major determinant of GH release after thyrotrophin-releasing hormone in adolescent diabetics.
    Edge JA; Human DH; Matthews DR; Dunger DB
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):397-404. PubMed ID: 2513149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-specific response of serum growth hormone to thyrotropin-releasing hormone in diabetics.
    Pan CY; Lu JM; Chang XM; Luo GC; Li H
    Chin Med J (Engl); 1989 Jan; 102(1):41-4. PubMed ID: 2504551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum growth hormone (GH) and the responses to thyrotropin-releasing hormone (TRH) in diabetes mellitus: lack of evidence for TRH evoked GH secretion.
    Small M; Cohen HN; MacLean JA; Beastall GH; MacCuish AC
    Diabetes Res; 1984 Jul; 1(2):89-94. PubMed ID: 6442227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone response to thyrotropin-releasing hormone in diabetes.
    Dasmahapatra A; Urdanivia E; Cohen MP
    J Clin Endocrinol Metab; 1981 May; 52(5):859-62. PubMed ID: 6785290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bromocriptine and the growth hormone response to thyroliberin in the insulin-dependent diabetic].
    Blickle JF; Schlienger JL; De Laharpe F; Stephan F
    Ann Endocrinol (Paris); 1984; 45(3):161-4. PubMed ID: 6441507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone, prolactin and thyrotrophin responses to thyrotrophin-releasing hormone in diabetic patients.
    Harrower AD
    Postgrad Med J; 1980 Jul; 56(657):481-4. PubMed ID: 6777767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRH-induced growth hormone release in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():119-22. PubMed ID: 6442706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous inhibition by pirenzepine of the GH responses to GnRH and TRH in insulin-dependent diabetics and in patients with major depression.
    Coiro V; Volpi R; Capretti L; Speroni G; Castelli A; Mosti A; Marchesi C; Gardini E; Rossi G; Chiodera P
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):143-8. PubMed ID: 2492706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth hormone secretion in response to the administration of thyrotropin releasing hormone (TRH) in children with insulin-dependent diabetes mellitus].
    Saggese G; Cesaretti G; Bracaloni C; Calisti L; Carlotti C; Cioni C
    Minerva Pediatr; 1992 May; 44(5):195-204. PubMed ID: 1620073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone response to thyrotropin-releasing hormone in acromegalic patients: reproducibility and dose-response study.
    Villabona CM; Soler J; Virgili N; Gómez JM; Montaña E; Navarro MA
    Horm Res; 1992; 37(1-2):14-17. PubMed ID: 1398470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonspecific growth hormone responses to thyrotropin-releasing hormone in insulin-dependent diabetes: sex- and age-related pituitary responsiveness.
    Ceda GP; Speroni G; Dall'Aglio E; Valenti G; Butturini U
    J Clin Endocrinol Metab; 1982 Jul; 55(1):170-4. PubMed ID: 6804482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Endokrynol Pol; 1992; 43(3):344-8. PubMed ID: 1345575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.
    Watanobe H; Sasaki S; Sone K; Takebe K
    J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradoxical response of growth hormone (GH) to thyrotropin-releasing hormone (TRH) in constitutionally tall children involves a cholinergic pathway.
    Arteaga E; Valenzuelaa P; Cattani A; del Valle M
    J Endocrinol Invest; 1989 Sep; 12(8):543-8. PubMed ID: 2512341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower 24-hour growth hormone levels in type I diabetics responding to thyrotropin-releasing hormone (TRH).
    Krassowski J; Szulc P; Kurta J; Jeske W; Zgliczyński S
    Endokrynol Pol; 1992; 43(3):336-42. PubMed ID: 1345574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.